Abstract
The conventional one-drug-one-disease theory has lost its sheen in multigenic diseases such as Alzheimer’s disease (AD). Propolis, a honeybee-derived product has ethnopharmacological evidence of antioxidant, anti-inflammatory, antimicrobial and neuroprotective properties. However, the chemical composition is complex and highly variable geographically. So, to leverage the potential of propolis as an effective treatment modality, it is essential to understand the role of each phytochemical in the AD pathophysiology. Therefore, the present study was aimed at investigating the anti-Alzheimer effect of bioactive in Indian propolis (IP) by combining LC–MS/MS fingerprinting, with network-based analysis and experimental validation. First, phytoconstituents in IP extract were identified using an in-house LC–MS/MS method. The drug likeness and toxicity were assessed, followed by identification of AD targets. The constituent–target–gene network was then constructed along with protein–protein interactions, gene pathway, ontology, and enrichment analysis. LC–MS/MS analysis identified 16 known metabolites with druggable properties except for luteolin-5-methyl ether. The network pharmacology-based analysis revealed that the hit propolis constituents were majorly flavonoids, whereas the main AD-associated targets were MAOB, ESR1, BACE1, AChE, CDK5, GSK3β, and PTGS2. A total of 18 gene pathways were identified to be associated, with the pathways related to AD among the topmost enriched. Molecular docking analysis against top AD targets resulted in suitable binding interactions at the active site of target proteins. Further, the protective role of IP in AD was confirmed with cell-line studies on PC-12, in situ AChE inhibition, and antioxidant assays.
Graphical abstract
Similar content being viewed by others
Abbreviations
- AD:
-
Alzheimer’s disease
- LC-MS:
-
Liquid chromatography hyphenated to mass spectrophotometer
- ARIA:
-
Amyloid-related imaging abnormalities
- IP:
-
Indian propolis
- HAR_PRP:
-
Haryana propolis
- PPI:
-
Protein–protein interaction
- KEGG:
-
Kyoto encyclopedia of genes and genomes
- DAVID:
-
Database for annotation visualization and integrated discovery
- Aβ:
-
Amyloid beta
- PC-12 cell line:
-
Rat pheochromocytoma cell line
- AChE:
-
Acetylcholinesterase
- BBB:
-
Blood–brain barrier
- BA:
-
Bioavailability score
- FDR:
-
False discovery rate
- PDB:
-
Protein data bank
- IC50 :
-
half maximal inhibitory concentration
- RMSD:
-
Root mean square deviation
- TIC:
-
Total ion chromatogram
- GO:
-
Gene ontology
- BP:
-
Biological process
- CC:
-
Cellular component
- MF:
-
Molecular function
- APP:
-
Amyloid precursor protein
- BACE1:
-
Beta-secretase 1
- GSK3β:
-
Glycogen synthase kinase-3 beta
- CDK5:
-
Cyclin-dependent kinase 5
- PTGS2:
-
Prostaglandin endoperoxide synthase 2
- AA:
-
Ascorbic acid
- mgEAA/g:
-
Milli gram equivalent of ascorbic acid/gram
References
Kumar A, Tiwari A, Sharma A (2018) Changing paradigm from one target one ligand towards multi-target directed ligand design for key drug targets of Alzheimer disease: an important role of in silico methods in multi-target directed ligands design. Curr Neuropharmacol 16:726–739. https://doi.org/10.2174/1570159x16666180315141643
Dienstmann R, Vermeulen L, Guinney J et al (2017) Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer. Nat Rev Cancer 17:79–92. https://doi.org/10.1038/nrc.2016.126
Crews L, Masliah E (2010) Molecular mechanisms of neurodegeneration in Alzheimer’s disease. Hum Mol Genet 19:R12–R20. https://doi.org/10.1093/hmg/ddq160
Van Dyck CH, Swanson CJ, Aisen P et al (2023) Lecanemab in early Alzheimer’s disease. N Engl J Med 388:142–143. https://doi.org/10.1056/nejmoa2212948
Cummings J, Rabinovici GD, Atri A et al (2022) Aducanumab: appropriate use recommendations update. J Prev Alzheimer’s Dis 9:221–230. https://doi.org/10.14283/jpad.2022.34
Atri A (2019) Current and future treatments in Alzheimer’s disease. Semin Neurol 39:227–240. https://doi.org/10.1055/s-0039-1678581
Eckert GP (2010) Traditional used plants against cognitive decline and Alzheimer disease. Front Pharmacol 1:1–10. https://doi.org/10.3389/fphar.2010.00138
Diddi S, Lohidasan S, Arulmozhi S, Mahadik KR (2023) Standardization and ameliorative effect of Kalyanaka ghrita in β-amyloid induced memory impairment in wistar rats. J Ethnopharmacol 300:1–18. https://doi.org/10.1016/j.jep.2022.115671
Brusotti G, Cesari I, Dentamaro A et al (2014) Isolation and characterization of bioactive compounds from plant resources: the role of analysis in the ethnopharmacological approach. J Pharm Biomed Anal 87:218–228. https://doi.org/10.1016/j.jpba.2013.03.007
Serby MJ, Burns SJ, Roane DM (2011) Treatment of memory loss with herbal remedies. Curr Treat Opt Neurol 13:520–528. https://doi.org/10.1007/s11940-011-0135-8
Solanki I, Parihar P, Mansuri ML, Parihar MS (2015) Flavonoid-based therapies in the early management of neurodegenerative diseases. Adv Nutr 6:64–72. https://doi.org/10.3945/an.114.007500
Sforcin JM (2016) Biological properties and therapeutic applications of propolis. Phytother Res 30:894–905. https://doi.org/10.1002/ptr.5605
Wagh VD (2013) Propolis: a wonder bees product and its pharmacological potentials. Adv Pharmacol Sci 2013:1–11. https://doi.org/10.1155/2013/308249
Necip A, Demirtas I, Tayhan SE et al (2023) Isolation of phenolic compounds from eco-friendly white bee propolis: antioxidant, wound-healing, and anti-Alzheimer effects. Food Sci Nutr 00:1–12. https://doi.org/10.1002/fsn3.3888
Nakajima Y, Shimazawa M, Mishima S, Hara H (2007) Water extract of propolis and its main constituents, caffeoylquinic acid derivatives, exert neuroprotective effects via antioxidant actions. Life Sci 80:370–377. https://doi.org/10.1016/j.lfs.2006.09.017
Nakajima Y, Shimazawa M, Mishima S, Hideaki H (2009) Neuroprotective effects of Brazilian green propolis and its main constituents against oxygen-glucose deprivation stress, with a gene-expression analysis. Phytother Res 23:1431–1438. https://doi.org/10.1002/ptr.2797
Nanaware S, Shelar M, Sinnathambi A et al (2017) Neuroprotective effect of Indian propolis in β-amyloid induced memory deficit: Impact on behavioral and biochemical parameters in rats. Biomed Pharmacother 93:543–553. https://doi.org/10.1016/j.biopha.2017.06.072
Bankova V, Bertelli D, Borba R et al (2019) Standard methods for Apis mellifera propolis research. J Apic Res 58:1–49. https://doi.org/10.1080/00218839.2016.1222661
Katekhaye S, Fearnley H, Fearnley J, Paradkar A (2019) Gaps in propolis research: challenges posed to commercialization and the need for an holistic approach. J Apic Res 58:604–616. https://doi.org/10.1080/00218839.2019.1614273
Kasote DM (2017) Propolis: a neglected product of value in the indian beekeeping sector. Bee World 94:80–83. https://doi.org/10.1080/0005772x.2017.1345223
Shao L, Ding Q, Wang X (2021) “Network target” theory and network pharmacology. In: Li S (ed) Network pharmacology. Springer, Singapore, pp 1–34
Hopkins AL (2008) Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 4:682–690. https://doi.org/10.1038/nchembio.118
Borse S, Joshi M, Saggam A et al (2021) Ayurveda botanicals in COVID-19 management: an in silico multi-target approach. PLoS ONE 16:1–33. https://doi.org/10.1371/journal.pone.0248479
Gao X, Li S, Cong C et al (2021) A network pharmacology approach to estimate potential targets of the active ingredients of epimedium for alleviating mild cognitive impairment and treating Alzheimer’s disease. Evid Based Complem Altern Med 2021:1–15. https://doi.org/10.1155/2021/2302680
Ibrahim RS, El-Banna AA (2021) Network pharmacology-based analysis for unraveling potential cancer-related molecular targets of Egyptian propolis phytoconstituents accompanied with molecular docking and in vitro studies. RSC Adv 11:11610–11626. https://doi.org/10.1039/d1ra01390d
Sankaran S, Dubey R, Lohidasan S (2023) Optimization of extraction conditions using response surface methodology and HPTLC fingerprinting analysis of Indian propolis. J Biol Act Prod Nat 13:76–93. https://doi.org/10.1080/22311866.2023.2185681
Ruch RJ, Cheng S, Klaunig JE (1989) Prevention of cytotoxicity and inhibition of intercellular communication by antioxidant catechins isolated from chinese green tea. Carcinogenesis 10:1003–1008. https://doi.org/10.1093/carcin/10.6.1003
Oyaizu M (1986) Studies on products of browning reaction. Antioxidative activities of products of browning reaction prepared from glucosamine. Jpn J Nutr Diet 44:307–315. https://doi.org/10.5264/eiyogakuzashi.44.307
Tolosa L, Donato MT, Gómez-Lechón MJ (2015) General cytotoxicity assessment by means of the MTT assay. In: Vinken M, Rogiers V (eds) Methods in molecular biology. Humana Press Inc, New York, pp 333–348
Dash UC, Sahoo AK (2017) In vitro antioxidant assessment and a rapid HPTLC bioautographic method for the detection of anticholinesterase inhibitory activity of Geophila repens. J Integr Med 15:231–241. https://doi.org/10.1016/S2095-4964(17)60326-1
Alzheimer’s Association (2023) 2023 Alzheimer’s disease facts and figures. Alzheimers Dement 19:1598–1695. https://doi.org/10.1002/alz.13016
Avula B, Sagi S, Masoodi MH et al (2020) Quantification and characterization of phenolic compounds from northern Indian propolis extracts and dietary supplements. J AOAC Int 103:1378–1393. https://doi.org/10.1093/jaoacint/qsaa032
Jerković I, Marijanović Z, Kuś PM, Tuberoso CIG (2016) Comprehensive study of Mediterranean (Croatian) propolis peculiarity: headspace, volatiles, anti-varroa-treatment residue, phenolics, and antioxidant properties. Chem Biodivers 13:210–218. https://doi.org/10.1002/cbdv.201500053
Saftić L, Peršurić Ž, Fornal E et al (2019) Targeted and untargeted LC–MS polyphenolic profiling and chemometric analysis of propolis from different regions of Croatia. J Pharm Biomed Anal 165:162–172. https://doi.org/10.1016/j.jpba.2018.11.061
Monteiro AFM, De Viana JO, Nayarisseri A et al (2018) Computational studies applied to flavonoids against Alzheimer’s and Parkinson’s diseases. Oxid Med Cell Longev 2018:1–21. https://doi.org/10.1155/2018/7912765
Mohd Sairazi NS, Sirajudeen KNS (2020) Natural products and their bioactive compounds: neuroprotective potentials against neurodegenerative diseases. Evid Based Complement Altern Med 2020:1–30. https://doi.org/10.1155/2020/6565396
Shahinozzaman M, Taira N, Ishii T et al (2018) Anti-inflammatory, anti-diabetic, and anti-Alzheimer’s effects of prenylated flavonoids from Okinawa propolis: an investigation by experimental and computational studies. Molecules 23:1–18. https://doi.org/10.3390/molecules23102479
Rafieian-Kopaei M, Hamedi A, Dehkordi ES et al (2020) Phytochemical investigation on volatile compositions and methoxylated flavonoids of Agrostis gigantea Roth. Iran J Pharm Res 19:360–370. https://doi.org/10.22037/ijpr.2019.15209.12935
Zahoor M, Khan I, Zeb A et al (2021) Pharmacological evaluation and in-silico modeling study of compounds isolated from Ziziphus oxyphylla. Heliyon 7:1–7. https://doi.org/10.1016/j.heliyon.2021.e06367
Youn K, Jun M (2012) Inhibitory effects of key compounds isolated from Corni fructus on bace1 activity. Phytother Res 26:1714–1718. https://doi.org/10.1002/ptr.4638
Yu XD, Zhang D, Xiao CL et al (2022) P-coumaric acid reverses depression-like behavior and memory deficit via inhibiting AGE-RAGE-mediated neuroinflammation. Cells 11:1–15. https://doi.org/10.3390/cells11101594
Liu R, Li J, Song J et al (2014) Pinocembrin improves cognition and protects the neurovascular unit in Alzheimer related deficits. Neurobiol Aging 35:1275–1285. https://doi.org/10.1016/j.neurobiolaging.2013.12.031
Huang L, Lin M, Zhong X et al (2019) Galangin decreases p-tau, Aβ 42 and β-secretase levels, and suppresses autophagy in okadaic acid-induced PC12 cells via an Akt/GSK3β/mTOR signaling-dependent mechanism. Mol Med Rep 19:1767–1774. https://doi.org/10.3892/mmr.2019.9824
Giacomeli R, de Gomes MG, Reolon JB et al (2020) Chrysin loaded lipid-core nanocapsules ameliorates neurobehavioral alterations induced by β-amyloid1-42 in aged female mice. Behav Brain Res 390:1–12. https://doi.org/10.1016/j.bbr.2020.112696
Ghaderi S, Gholipour P, Komaki A et al (2022) p-Coumaric acid ameliorates cognitive and non-cognitive disturbances in a rat model of Alzheimer’s disease: the role of oxidative stress and inflammation. Int Immunopharmacol. https://doi.org/10.1016/j.intimp.2022.109295
Bu J, Zhang Y, Mahan Y et al (2022) Acacetin improves cognitive function of APP/PS1 Alzheimer’s disease model mice via the NLRP3 inflammasome signaling pathway. Transl Neurosci 13:390–397. https://doi.org/10.1515/tnsci-2022-0254
Boisard S, Le Ray AM, Gatto J et al (2014) Chemical composition, antioxidant and anti-AGEs activities of a French poplar type propolis. J Agric Food Chem 62:1344–1351. https://doi.org/10.1021/jf4053397
Gu L, Lu J, Li Q et al (2020) A network-based analysis of key pharmacological pathways of Andrographis paniculata acting on Alzheimer’s disease and experimental validation. J Ethnopharmacol 251:1–12. https://doi.org/10.1016/j.jep.2019.112488
Zhang YW, Thompson R, Zhang H, Xu H (2011) APP processing in Alzheimer’s disease. Mol Brain 4:1–13. https://doi.org/10.1186/1756-6606-4-3
Coimbra JRM, Marques DFF, Baptista SJ et al (2018) Highlights in BACE1 inhibitors for Alzheimer’s disease treatment. Front Chem 6:1–10. https://doi.org/10.3389/fchem.2018.00178
Chen JJ, Liu Q, Yuan C et al (2015) Development of 2-aminooxazoline 3-azaxanthenes as orally efficacious β-secretase inhibitors for the potential treatment of Alzheimer’s disease. Bioorg Med Chem Lett 25:767–774. https://doi.org/10.1016/j.bmcl.2014.12.092
Halder D, Das S (2022) Role of multi-targeted bioactive natural molecules and their derivatives in the treatment of Alzheimer’s disease: an insight into structure-activity relationship. J Biomol Struct Dyn 0:1–38. https://doi.org/10.1080/07391102.2022.2158136
Liu SL, Wang C, Jiang T et al (2016) The role of Cdk5 in Alzheimer’s disease. Mol Neurobiol 53:4328–4342. https://doi.org/10.1007/s12035-015-9369-x
Sayas CL, Ávila J (2021) GSK-3 and tau: a key duet in Alzheimer’s disease. Cells 10:1–19. https://doi.org/10.3390/cells10040721
Trott O, Olson AJ (2009) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455–461. https://doi.org/10.1002/jcc.21334
Syaifie PH, Hemasita AW, Nugroho DW et al (2022) In silico investigation of propolis compounds as potential neuroprotective agent. Biointerface Res Appl Chem 12:8285–8306. https://doi.org/10.33263/BRIAC126.82858306
de Sousa NF, Scotti L, de Moura ÉP et al (2021) Computer aided drug design methodologies with natural products in the drug research against Alzheimer’s disease. Curr Neuropharmacol 20:857–885. https://doi.org/10.2174/1570159x19666211005145952
Shrestha S, Natarajan S, Park JH et al (2013) Potential neuroprotective flavonoid-based inhibitors of CDK5/p25 from Rhus parviflora. Bioorg Med Chem Lett 23:5150–5154. https://doi.org/10.1016/j.bmcl.2013.07.020
Ma SL, Tang NLS, Zhang YP et al (2008) Association of prostaglandin-endoperoxide synthase 2 (PTGS2) polymorphisms and Alzheimer’s disease in Chinese. Neurobiol Aging 29:856–860. https://doi.org/10.1016/j.neurobiolaging.2006.12.011
Ye J, Li L, Hu Z (2021) Exploring the molecular mechanism of action of yinchen wuling powder for the treatment of hyperlipidemia, using network pharmacology, molecular docking, and molecular dynamics simulation. Biomed Res Int 2021:1–14. https://doi.org/10.1155/2021/9965906
Laskar RA, Sk I, Roy N, Begum NA (2010) Antioxidant activity of Indian propolis and its chemical constituents. Food Chem 122:233–237. https://doi.org/10.1016/j.foodchem.2010.02.068
Bonamigo T, Campos JF, Alfredo TM et al (2017) Antioxidant, cytotoxic, and toxic activities of propolis from two native bees in Brazil: Scaptotrigona depilis and Melipona quadrifasciata anthidioides. Oxid Med Cell Longev 2017:1–12. https://doi.org/10.1155/2017/1038153
Ramnath S, Venkataramegowda S (2016) Antioxidant activity of Indian propolis—an in vitro evaluation. Int J Pharmacol Phytochem Ethnomed 5:79–85. https://doi.org/10.18052/www.scipress.com/ijppe.5.79
Kasote DM, Pawar MV, Bhatia RS et al (2017) HPLC, NMR based chemical profiling and biological characterisation of Indian propolis. Fitoterapia 122:52–60. https://doi.org/10.1016/j.fitote.2017.08.011
Hou XQ, Yan R, Yang C et al (2014) A novel assay for high-throughput screening of anti-Alzheimer’s disease drugs to determine their efficacy by real-time monitoring of changes in PC12 cell proliferation. Int J Mol Med 33:543–549. https://doi.org/10.3892/ijmm.2013.1608
Park SY, Kim HS, Cho EK et al (2008) Curcumin protected PC12 cells against beta-amyloid-induced toxicity through the inhibition of oxidative damage and tau hyperphosphorylation. Food Chem Toxicol 46:2881–2887. https://doi.org/10.1016/j.fct.2008.05.030
Khan H, Marya, Amin S et al (2018) Flavonoids as acetylcholinesterase inhibitors: current therapeutic standing and future prospects. Biomed Pharmacother 101:860–870. https://doi.org/10.1016/j.biopha.2018.03.007
Guo AJY, Xie HQ, Choi RCY et al (2010) Galangin, a flavonol derived from Rhizoma Alpiniae Officinarum, inhibits acetylcholinesterase activity in vitro. Chem Biol Interact 187:246–248. https://doi.org/10.1016/j.cbi.2010.05.002
Acknowledgements
The authors are grateful to the All-India Council for Technical Education (AICTE) for providing financial assistance to Sandeep Sankaran through the AICTE Doctoral Fellowship Scheme (ADF). The authors would like to acknowledge Dr Sangram Patil, Mr Amol Kadam, and the Centre of Food Testing Laboratories, Pune for their support in LC-MS/MS work. The authors are thankful to Dr Amol Jadhav, and Nirav BioSolutions, Pune for their help in carrying out the cell viability assay.
Funding
This research did not receive any specific grant from funding agencies for carrying out this work.
Author information
Authors and Affiliations
Contributions
S.S: performed LC-MS/MS, network pharmacology, molecular docking, in-vitro experiments, and wrote the manuscript. R.D: helped in LC-MS/MS and in-vitro experiments. A.G: assisted in molecular docking studies, Writing - review. RC: helped in network pharmacology analysis. A.K: helped in in-vitro experiments. S.L: conceptualized and designed the work, provided reagents and facilities, Supervision, Writing - review and editing.
Corresponding author
Ethics declarations
Competing interests
The authors declare that they have no conflicts of interest relevant to the publication of this article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sankaran, S., Dubey, R., Gomatam, A. et al. Deciphering the multi-functional role of Indian propolis for the management of Alzheimer’s disease by integrating LC–MS/MS, network pharmacology, molecular docking, and in-vitro studies. Mol Divers (2024). https://doi.org/10.1007/s11030-024-10818-8
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11030-024-10818-8